221 results Stibbe advises Vistra Stibbe advises French public infrastructure investment fund Stibbe advised a French public infrastructure investment fund on the acquisition of an interest in a German wind farm project. Stibbe advises group of investors led by Joh. A. Benckiser Stibbe advised a group of investors led by Joh. A. Benckiser on its bid for all outstanding shares of D.E MASTER BLENDERS 1753 N.V. Stibbe advises leading pharmaceutical company Stibbe assisted a leading pharmaceutical company in identifying the most cost-effective way to obtain in Belgium an improved pricing and reimbursement for new fixed-dose combination products composed of off-patent ingredients. Stibbe advises Canon Advising Canon in connection with their dispute with the State of the Netherlands on the procurement of framework contracts. Case won up to and including the Supreme Court. Stibbe advises Rhône Capital Stibbe advised Rhône Capital on its acquisition - and on the financing, tax, IP and employment aspects - of CSM’s Bakery Supplies business for an enterprise value of EUR 1,05 billion. Stibbe advises on additional notes offering of NXP Semiconductors Stibbe advises Barclays on the additional notes offering of NXP Semiconductors for an amount of USD 500 million. Stibbe advises Mylan Stibbe advises global pharmaceutical company Mylan on the merger control aspects of its USD 7.2 billion acquisition of Swedish drugmaker Meda. Stibbe advises Aedifica Stibbe advises Aedifica, a Belgian listed company investing in health care real estate, on reaching agreement to acquire two new senior housing sites in Lochem and Rotterdam. Stibbe advises Aedifica Stibbe advises Aedifica, a Belgian listed company investing in health care real estate, on the acquisition of a new senior housing site in Arnhem. This is the second investment of Aedifica in The Netherlands. Aedifica has developed a portfolio of health Stibbe advises Sonova Holding AG Stibbe has advised Sonova Holding AG on its acquisition of AudioNova B.V. from HAL Investments. The value of AudioNova is EUR 830 million. Stibbe advises Aedifica Stibbe advises Aedifica, a Belgian listed company investing in health care real estate, on its acquisition of four senior housing sites in The Netherlands. Stibbe advises NN Group Stibbe advises NN Group on the sale of its wholly owned private equity management company, Parcom Capital Management, to its directors. Stibbe represents Mylan On 27 July 2015, Teva Pharmaceutical Industries announced that it has withdrawn its previously announced hostile bid to acquire Mylan N.V. Stibbe represented Mylan in this successful takeover defence and advised Mylan on both litigation and EU competition Stibbe advises Tornier Stibbe advises Tornier N.V. on its merger with Wright Medical Group, Inc. in an all stock transaction with a combined equity value of approximately $3.3 billion. Stibbe advises on the IPO of Pershing Square Holdings Stibbe advises Pershing Square Holdings, Ltd. on the IPO of this investment fund managed by the leading active investor Bill Ackmann. Stibbe advises Mylan Stibbe advises Mylan Inc., the pharmaceuticals company listed on the NASDAQ with a market cap of approximately $19 billion, on the inversion acquisition of Abbott’s non-U.S. developed markets specialty and branded generics business. Stibbe advises Investcorp on the acquisition of SPGPrints Stibbe advises Investcorp, a global provider and manager of alternative investment products, on its acquisition of SPGPrints Group from funds managed by Bencis Capital Partners. Pagination Previous page Page 9 Current page 10 Page 11 Page 12 Next page
Stibbe advises French public infrastructure investment fund Stibbe advised a French public infrastructure investment fund on the acquisition of an interest in a German wind farm project.
Stibbe advises group of investors led by Joh. A. Benckiser Stibbe advised a group of investors led by Joh. A. Benckiser on its bid for all outstanding shares of D.E MASTER BLENDERS 1753 N.V.
Stibbe advises leading pharmaceutical company Stibbe assisted a leading pharmaceutical company in identifying the most cost-effective way to obtain in Belgium an improved pricing and reimbursement for new fixed-dose combination products composed of off-patent ingredients.
Stibbe advises Canon Advising Canon in connection with their dispute with the State of the Netherlands on the procurement of framework contracts. Case won up to and including the Supreme Court.
Stibbe advises Rhône Capital Stibbe advised Rhône Capital on its acquisition - and on the financing, tax, IP and employment aspects - of CSM’s Bakery Supplies business for an enterprise value of EUR 1,05 billion.
Stibbe advises on additional notes offering of NXP Semiconductors Stibbe advises Barclays on the additional notes offering of NXP Semiconductors for an amount of USD 500 million.
Stibbe advises Mylan Stibbe advises global pharmaceutical company Mylan on the merger control aspects of its USD 7.2 billion acquisition of Swedish drugmaker Meda.
Stibbe advises Aedifica Stibbe advises Aedifica, a Belgian listed company investing in health care real estate, on reaching agreement to acquire two new senior housing sites in Lochem and Rotterdam.
Stibbe advises Aedifica Stibbe advises Aedifica, a Belgian listed company investing in health care real estate, on the acquisition of a new senior housing site in Arnhem. This is the second investment of Aedifica in The Netherlands. Aedifica has developed a portfolio of health
Stibbe advises Sonova Holding AG Stibbe has advised Sonova Holding AG on its acquisition of AudioNova B.V. from HAL Investments. The value of AudioNova is EUR 830 million.
Stibbe advises Aedifica Stibbe advises Aedifica, a Belgian listed company investing in health care real estate, on its acquisition of four senior housing sites in The Netherlands.
Stibbe advises NN Group Stibbe advises NN Group on the sale of its wholly owned private equity management company, Parcom Capital Management, to its directors.
Stibbe represents Mylan On 27 July 2015, Teva Pharmaceutical Industries announced that it has withdrawn its previously announced hostile bid to acquire Mylan N.V. Stibbe represented Mylan in this successful takeover defence and advised Mylan on both litigation and EU competition
Stibbe advises Tornier Stibbe advises Tornier N.V. on its merger with Wright Medical Group, Inc. in an all stock transaction with a combined equity value of approximately $3.3 billion.
Stibbe advises on the IPO of Pershing Square Holdings Stibbe advises Pershing Square Holdings, Ltd. on the IPO of this investment fund managed by the leading active investor Bill Ackmann.
Stibbe advises Mylan Stibbe advises Mylan Inc., the pharmaceuticals company listed on the NASDAQ with a market cap of approximately $19 billion, on the inversion acquisition of Abbott’s non-U.S. developed markets specialty and branded generics business.
Stibbe advises Investcorp on the acquisition of SPGPrints Stibbe advises Investcorp, a global provider and manager of alternative investment products, on its acquisition of SPGPrints Group from funds managed by Bencis Capital Partners.